Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [4]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-20080 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- UBC13 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- A suggested positive control is human small intestine tissue lysate.
- Concentration
- 1 mg/mL
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of human small intestine cell lysates using a UBC13 polyclonal antibody (Product # PA5-20080) at (A) 0.5, (B) 1, and (C) 2 µg/mL.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western Blot analysis of UBC13 in human small intestine cell lysates with UBC13 Polyclonal Antibody (Product # PA5-20080) at (A) 0.5, (B) 1, and (C) 2 µg/mL.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Knockdown of UBE2N was achieved by transfecting Hep G2 with UBE2N specific siRNAs (Silencer® select Product # s14596, s14595). Western blot analysis (Fig. a) was performed using whole cell extracts from the UBE2N knockdown cells (lane 3), non-specific scrambled siRNA transfected cells (lane 2) and untransfected cells (lane 1). The blot was probed with UBC13 Polyclonal Antibody (Product # PA5-20080, 1:1000 dilution) and Goat anti-Rabbit IgG (H+L) Superclonal™ Recombinant Secondary Antibody, HRP (Product # A27036, 0.25µg/ml, 1:4000 dilution). Densitometric analysis of this western blot is shown in histogram (Fig. b). Decrease in signal upon siRNA mediated knock down confirms that antibody is specific to UBE2N.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot was performed using anti-UBC13 Polyclonal Antibody (Product # PA5-20080) and a 17 kDa band corresponding to UBE2N was observed across all the cell lines and tissues tested. Whole cell extracts (30 µg lysate) of A431 (Lane 1), HepG2 (Lane 2), HeLa (Lane 3), NIH:OVCAR-3 (Lane 4), BeWo (Lane 5), HL60 (Lane 6), MOLT-4 (Lane 7), tissue extracts of Mouse Testis (Lane 8), Mouse Brain (Lane 9), Mouse Liver (Lane 10) and Mouse Ovary (Lane 11) were electrophoresed using NuPAGE™ 4-12% Bis-Tris Protein Gel (Product # NP0322BOX). Resolved proteins were then transferred onto a nitrocellulose membrane (Product # IB23001) by iBlot® 2 Dry Blotting System (Product # IB21001). The blot was probed with the primary antibody (1:1000 dilution) and detected by chemiluminescence with Goat anti-Rabbit IgG (H+L) Superclonal™ Recombinant Secondary Antibody, HRP (Product # A27036, 1:4000 dilution) using the iBright FL 1000 (Product # A32752). Chemiluminescent detection was performed using Novex® ECL Chemiluminescent Substrate Reagent Kit (Product # WP20005).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescence of UBC13 in Mouse Thymus cells with UBC13 Polyclonal Antibody (Product # PA5-20080) at 10 µg/mL.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemistry of UBC13 in mouse thymus tissue with UBC13 Polyclonal Antibody (Product # PA5-20080) at 2 µg/mL.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemistry of UBC13 in mouse thymus tissue with UBC13 Polyclonal Antibody (Product # PA5-20080) at 2.5 µg/mL.
